Vaheh Oganesyan
6Patents
3h-index
21Co-inventors
53Inventor score
Filing activity: Dec 10, 2009 → Jul 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9527905B2 | Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of use | Emerging Cross-Sectional Technologies | 18 | Active |
| US9527927B2 | Modified polypeptides for bispecific antibody scaffolds | Chemistry; Metallurgy | 18 | Active |
| US10000553B2 | CD40L-specific TN3-derived scaffolds and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US11104720B2 | Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific monomer subunit | Chemistry; Metallurgy | 1 | Active |
| US11555062B2 | Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomer | Chemistry; Metallurgy | 0 | Active |
| US8775090B2 | Crystals and structure of a human IgG Fc variant with enhanced FcRn binding | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.